Progyny Inc

12 sie 2026, 20:01 UTC

Progyny Inc shares are lower following a Barclays downgrade, which cut the price target to $30 from $34, citing performance concerns.

11 sie 2026, 20:02 UTC

Progyny Inc's stock is declining after a disappointing revenue forecast, despite strong second-quarter results that exceeded analyst expectations.

7 sie 2026, 20:02 UTC

Progyny Inc's shares are lower after a cautious Q3 sales outlook, despite reporting revenue of $350.5 million that exceeded analyst expectations.

6 sie 2026, 23:02 UTC

Progyny Inc shares are lower in after-market trading following a revenue guidance cut to $1.36 billion to $1.39 billion, below previous estimates.

31 lip 2026, 19:46 UTC

Progyny Inc shares are lower today amid broader market pressures and rising bond yields. No specific company news was identified to explain the decline.

30 lip 2026, 21:02 UTC

Progyny Inc shares are lower in after-market hours, with no specific news identified for the decline. The stock is below its 20-day moving average.

29 lip 2026, 18:55 UTC

Progyny Inc shares are higher today, reflecting notable strength in trading. The stock remains above its 20-day moving average.

28 lip 2026, 17:41 UTC

Progyny Inc shares are lower following a downgrade by Barclays, which noted slowing website traffic growth at fertility clinics. Price target raised to $34 from $27.

24 lip 2026, 15:06 UTC

BTIG maintained its Buy rating on Progyny and raised the price target to $40. Shares are trading higher, remaining above the 20-day moving average.

22 lip 2026, 20:01 UTC

Progyny Inc shares are lower despite the acceptance of benefits at Pinnacle Fertility New York, enhancing access to reproductive care for members.

20 lip 2026, 17:16 UTC

Progyny Inc shares are higher today, maintaining a position near their one-month trading range. No specific news was identified to explain the movement.